138
Participants
Start Date
July 15, 2020
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Niraparib
PARP Inhibitor
Niraparib + TSR-042 (Dostarlimab)
Combination of 2 drugs, a PARP Inhibitor and an Anti-PD-1
Chemotherapy Drugs
Chemotherapies given in standard of care
RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
Centre François Baclesse, Caen
NOT_YET_RECRUITING
Centre Georges François Leclerc, Dijon
ACTIVE_NOT_RECRUITING
CHRU Jean Minjoz, Besançon
NOT_YET_RECRUITING
CHU de BREST - Hôpital Cavale Blanche, Brest
NOT_YET_RECRUITING
Centre Hospitalier Universitaire de Nîmes, Institut de Cancérologie du GARD, Nîmes
ACTIVE_NOT_RECRUITING
IUCT Oncopole - Institut Claudius Régaud, Toulouse
ACTIVE_NOT_RECRUITING
Centre Régional de Lutte contre le cancer - Institut Bergonié, Bordeaux
RECRUITING
Centre Eugène Marquis, Rennes
NOT_YET_RECRUITING
CHU Saint-Etienne - Pôle de Cancérologie, Saint-Priest-en-Jarez
ACTIVE_NOT_RECRUITING
Hôpital Privé du Confluent S.A.S., Nantes
ACTIVE_NOT_RECRUITING
ICO - Centre René Gauducheau, Saint-Herblain
NOT_YET_RECRUITING
ICO Paul Papin, Angers
NOT_YET_RECRUITING
ICL - Centre Alexis Vautrin, Vandœuvre-lès-Nancy
RECRUITING
Centre Oscar Lambret, Lille
ACTIVE_NOT_RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
ICANS, Strasbourg
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Groupe Hospitalier des Diaconesses Croix Saint-Simon, Paris
RECRUITING
Institut Curie, Paris
ACTIVE_NOT_RECRUITING
Hopital Milétrie - Centre Hospitalier Universitaire Poitiers, Poitiers
NOT_YET_RECRUITING
CHU de Limoges - Hôpital Dupuytren, Limoges
ACTIVE_NOT_RECRUITING
Institut Gustave Roussy, Villejuif
Tesaro, Inc.
INDUSTRY
ARCAGY/ GINECO GROUP
OTHER